Skip to main navigation Skip to search Skip to main content

Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk

  • William W. Greenwald
  • , Joshua Chiou
  • , Jian Yan
  • , Yunjiang Qiu
  • , Ning Dai
  • , Allen Wang
  • , Naoki Nariai
  • , Anthony Aylward
  • , Jee Yun Han
  • , Nikita Kadakia
  • , Laura Regue
  • , Mei-Lin Okino
  • , Frauke Drees
  • , Dana Kramer
  • , Nicholas Vinckier
  • , Liliana Minichiello
  • , David Gorkin
  • , Joseph Avruch
  • , Kelly A. Frazer
  • , Maike Sander
  • Bing Ren, Kyle J. Gaulton*
*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

47 Downloads (CityUHK Scholars)

Abstract

Genetic variants affecting pancreatic islet enhancers are central to T2D risk, but the gene targets of islet enhancer activity are largely unknown. We generate a high-resolution map of islet chromatin loops using Hi-C assays in three islet samples and use loops to annotate target genes of islet enhancers defined using ATAC-seq and published ChIP-seq data. We identify candidate target genes for thousands of islet enhancers, and find that enhancer looping is correlated with islet-specific gene expression. We fine-map T2D risk variants affecting islet enhancers, and find that candidate target genes of these variants defined using chromatin looping and eQTL mapping are enriched in protein transport and secretion pathways. At IGF2BP2, a fine-mapped T2D variant reduces islet enhancer activity and IGF2BP2 expression, and conditional inactivation of IGF2BP2 in mouse islets impairs glucose-stimulated insulin secretion. Our findings provide a resource for studying islet enhancer function and identifying genes involved in T2D risk.

Original languageEnglish
Article number2078
Number of pages12
JournalNature Communications
Volume10
Online published7 May 2019
DOIs
Publication statusPublished - 7 May 2019
Externally publishedYes

Funding

Support for this work was provided by NIH funding U01DK105541 to M.S., K.A.F. and B.R., R01DK114650 to K.G., U01DK112155 to M.S. and K.A.F. and R37DK017776 and P30DK057521 to J.A., the Ludwig Institute for Cancer Research to B.R., postdoc fellowship 537-2014-6796 from the Swedish Vetenskapsradet to J.Y., fellowship F31HL142151 to W.W.G. and JDRF-3-2012-177 postdoc fellowship to A.W., D.K. and L.M. thank the EMBL-Monterotondo gene expression and transgenic services for the production of the Imp2 floxed line. L.M. was supported in part by the Lundbeck foundation (177/05) and EMBL-Mouse Biology Unit. D.K. was supported by an EMBL-postdoctoral fellowship. Funding for mouse experiments was provided by the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Foundation in Mexico.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • GENOME-WIDE ASSOCIATION
  • GENE-EXPRESSION
  • READ ALIGNMENT
  • ANNOTATION
  • DISCOVERY
  • CELL
  • SEQ
  • PROVIDES
  • ELEMENTS
  • SUITE

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk'. Together they form a unique fingerprint.

Cite this